Ridaura Capsule
Product Images NDC 54766-093

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ridaura (NDC 54766-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sebela Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ca09306001 Ridaura 3mg

RIDAURA 3 mg capsules packaging label by Sebela Pharmaceuticals Inc. The label shows a 60-capsule carton for oral administration containing auranofin 3 mg per capsule. The label includes dosage information, storage instructions, inactive ingredients, and distributor contact details. Barcodes and regulatory text are also visible on the label.*

FDA Label Image

Lb09306001

RIDAURA 3 mg capsules label by Sebela Pharmaceuticals Inc. It shows the product name with the generic ingredient auranofin, dosage strength of 3 mg, and quantity of 60 capsules. The label includes storage instructions to keep between 15°-30°C (59°-86°F), dosage directions for adults, and distributor contact information. The label features two barcodes and the NDC 54766-093-06.*

FDA Label Image

Chemical Structure (Rid01 0003 01)

Chemical structure of auranofin showing its molecular components including gold (Au) atom bonded to phosphorus and thiol groups attached to an acetylated sugar moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.